| 中國醫藥大學 |
2012-03 |
Clinical imaging findings in a girl with Hutchinson-Gilford progeria syndrome
|
陳持平(Chih-Ping Chen)*;(Shuan-Pei Lin);(Dar-Shong Lin);(Yu-Peng Liu);(Lee James Hsu);(Wayseen Wang) |
| 嘉南藥理大學 |
2009 |
Clinical Immunology
|
Elsevier SDOL |
| 嘉南藥理大學 |
2009 |
Clinical Immunology and Immunopathology
|
Elsevier SDOL |
| 嘉南藥理大學 |
2009 |
Clinical Immunology Newsletter
|
Elsevier SDOL |
| 國立成功大學 |
2021 |
Clinical impact and risk factors of nonsusceptibility to third-generation cephalosporins among hospitalized adults with monomicrobial enterobacteriaceae bacteremia in southern Taiwan: A multicenter study
|
Lin, T.-C.;Hung, Y.-P.;Lee, C.-C.;Lin, W.-T.;Huang, L.-C.;Dai, W.;Kuo, C.-S.;Ko, W.-C.;Huang, Y.-L. |
| 國立臺灣大學 |
2002 |
Clinical Impact of (18)F Fdg-Pet in Patients with Suspected Recurrent Breast Cancer Based on Asymptomatically Elevated Tumor Marker Serum Levels : A Preliminary Report
|
顏若芳; YEN, RUOH-FANG |
| 臺大學術典藏 |
2018-09-10T07:24:09Z |
Clinical impact of 18F-FDG PET on the management of patients with early non-small-cell lung cancer by conventional workup.
|
RUOH-FANG YEN; RUOH-FANG YEN |
| 中國醫藥大學 |
2002-07 |
Clinical impact of 18F-FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels A preliminary report.
|
劉秋松(Liu,Chiu-Shong); (Yeh-You Shen); 林正介(Lin,Cheng-Chieh); (Ruoh-Fang Yan); 高嘉鴻(Kao,Chia-Hung)* |
| 國立成功大學 |
2012-07 |
Clinical impact of BI-RADS classification in Taiwanese breast cancer patients: BI-RADS 5 versus BI-RADS 0-4
|
Kuo, Yao-Lung; Cheng, Lili; Chang, Tsai-Wang |
| 國立成功大學 |
2021-02 |
Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia
|
Lee;Nan-Yao;Lo;Ching-Lung;Chen;Po-Lin;Syue;Ling-Shan;Li;Chia-Wen;Li;Ming-Chi;Ko;Wen-Chien |
| 國家衛生研究院 |
2015-06 |
Clinical impact of Clostridium difficile colonization
|
Hung, YP;Lee, JC;Lin, HJ;Liu, HC;Wu, YH;Tsai, PJ;Ko, WC |
| 國立臺灣大學 |
2007 |
Clinical Impact of Gb Virus C Viremia on Patients with Hiv Type 1 Infection in the Era of Highly Active Antiretroviral Therapy
|
盛望徽; 洪健清; 王振泰; 陳培哲; 張上淳; 高嘉宏; SHENG, WANG-HUEI; HUNG, CHIEN-CHING; WANG, JANN-TAY; CHEN, PEI-JER; CHANG, SHAN-CHWEN; KAO, JIA-HORNG |
| 國立臺灣大學 |
2006-02 |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng, WH (Sheng, Wang-Huei); Hung, CC (Hung, Chien-Ching); Wu, RJ (Wu, Ruei-Jiuan); Wang, JT (Wang, Jann-Tay); Chen, PJ (Chen, Pei-Jer); Chang, SC (C |
| 臺大學術典藏 |
2018-09-10T06:27:52Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
SHAN-CHWEN CHANG; JIA-HORNG KAO; JANN-TAY WANG; CHIEN-CHING HUNG; Sheng, W.-H. and Hung, C.-C. and Wu, R.-J. and Wang, J.-T. and Chen, P.-J. and Chang, S.-C. and Kao, J.-H.; PEI-JER CHEN; WANG-HUEI SHENG |
| 臺大學術典藏 |
2020-09-30T03:23:05Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Kao J.-H.; Chang S.-C.; Chen P.-J.; Wang J.-T.; Sheng W.-H.;Chien-Ching Hung;Wu R.-J.;Wang J.-T.;Chen P.-J.;Chang S.-C.;Kao J.-H.; Sheng W.-H.; CHIEN-CHING HUNG; Wu R.-J. |
| 臺大學術典藏 |
2020-12-29T03:08:52Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng W.-H.;Hung C.-C.;Wu R.-J.;Jann-Tay Wang;Chen P.-J.;Chang S.-C.;Kao J.-H.; Kao J.-H.; Sheng W.-H.; Hung C.-C.; Wu R.-J.; JANN-TAY WANG; Chen P.-J.; Chang S.-C. |
| 臺大學術典藏 |
2007 |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Wang J.-T.; Wu R.-J.; Hung C.-C.; Sheng W.-H.; Chen P.-J.; SHAN-CHWEN CHANG; Kao J.-H. |
| 臺大學術典藏 |
2021-02-26T02:00:18Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Wang-Huei Sheng;Hung C.-C.;Wu R.-J.;Wang J.-T.;Chen P.-J.;Chang S.-C.;Kao J.-H.; WANG-HUEI SHENG; Hung C.-C.; Wu R.-J.; Wang J.-T.; Chen P.-J.; Chang S.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:35:07Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Wu R.-J.; Wang J.-T.; PEI-JER CHEN; Chang S.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:42Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Wu R.-J.; Wang J.-T.; Chen P.-J.; Chang S.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-05-13T08:05:08Z |
Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Wu R.-J.; JANN-TAY WANG; Chen P.-J.; Chang S.-C.; Kao J.-H. |
| 國立臺灣大學 |
2007-11 |
Clinical impact of GB virus C viremia on patients with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy.
|
Sheng, WH; Hung, CC; Wang, RJ; Wang, JT; Chen, PJ; Chang, SC; Kao, JH. |
| 臺大學術典藏 |
2021-07-22T06:25:01Z |
Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma
|
CHIH-YANG HSIAO; Yang P.-C.; Li X.; Huang K.-W. |
| 臺大學術典藏 |
2021-04-29T06:52:42Z |
Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma
|
Hsiao, Chih-Yang;Yang, Po-Chih;Li, Xiaoyong;Kai-Wen Huang; Hsiao, Chih-Yang; Yang, Po-Chih; Li, Xiaoyong; KAI-WEN HUANG |
| 中山醫學大學 |
2020 |
Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
|
Chen, YY; Wang, CC; Liu, YW; Li, WF; Chen, YH |
